Increasing access to nicotine replacement therapy in community stores
Evaluating a novel policy to increase access to nicotine replacement therapy in community retailers
This study is looking at a new rule that makes it easier for people in certain neighborhoods to buy products that help them quit smoking, and it wants to see how well stores are following this rule and how it helps people get the support they need to stop smoking, especially in communities that have been affected by tobacco use.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10790803 on NIH RePORTER |
What this research studies
This research investigates a new policy that requires community retailers to sell nicotine replacement therapy (NRT) products, aiming to improve access for individuals in areas with high tobacco exposure and limited pharmacy access. The project will assess how well these retailers comply with the new law and analyze its impact on NRT sales and calls to quit smoking services. By focusing on diverse neighborhoods, the research seeks to understand the effects of this policy on different racial and ethnic groups, ultimately aiming to reduce health disparities related to tobacco use.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in communities with high tobacco product exposure and limited access to pharmacies, particularly from diverse racial and ethnic backgrounds.
Not a fit: Patients who do not smoke or are not interested in quitting smoking may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to smoking cessation resources for underserved populations, helping more individuals quit smoking.
How similar studies have performed: Similar policy interventions in other regions have shown promise in increasing access to cessation resources, suggesting potential success for this approach.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Hrywna, Maria — Rutgers Biomedical and Health Sciences
- Study coordinator: Hrywna, Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.